APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Preventable Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pediatric Preventable Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchPediatric Preventable Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Preventable Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pediatric Preventable Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Preventable Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Preventable Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pediatric Preventable Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pediatric Preventable Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Preventable Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Preventable Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pediatric Preventable Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Preventable Vaccine include Sanofi Pasteur, Johnson & Johnson (Janssen), Pfizer Inc., GlaxoSmithKline plc (GSK), Sinovac Biotech, Sinopharm Group Co.,, Serum Institute of India Pvt., Novavax, Inc. and Moderna, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Preventable Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Preventable Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Preventable Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Preventable Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Preventable Vaccine Segment by Company

Sanofi Pasteur

Johnson & Johnson (Janssen)

Pfizer Inc.

GlaxoSmithKline plc (GSK)

Sinovac Biotech

Sinopharm Group Co.,

Serum Institute of India Pvt.

Novavax, Inc.

Moderna, Inc.

Merck & Co., Inc.

Emergent BioSolutions Inc.

Daiichi Sankyo Company

CSL Limited (Seqirus)

Bharat Biotech International

AstraZeneca plc

Pediatric Preventable Vaccine Segment by Type

Subunit Vaccines

Inactivated Vaccines

Live Vaccines

Viral Vector Vaccines

Mrna Vaccines

Pediatric Preventable Vaccine Segment by Application

Bacterial Diseases

Virus Diseases

Pediatric Preventable Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Preventable Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Preventable Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Preventable Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Preventable Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Preventable Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pediatric Preventable Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pediatric Preventable Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pediatric Preventable Vaccine Industry Trends Table 2. Pediatric Preventable Vaccine Industry Drivers Table 3. Pediatric Preventable Vaccine Industry Opportunities and Challenges Table 4. Pediatric Preventable Vaccine Industry Restraints Table 5. Global Pediatric Preventable Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pediatric Preventable Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pediatric Preventable Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers Table 9. Global Pediatric Preventable Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pediatric Preventable Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pediatric Preventable Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pediatric Preventable Vaccine Manufacturers, Product Type & Application Table 13. Global Pediatric Preventable Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Preventable Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Subunit Vaccines Table 17. Major Manufacturers of Inactivated Vaccines Table 18. Major Manufacturers of Live Vaccines Table 19. Major Manufacturers of Viral Vector Vaccines Table 20. Major Manufacturers of Mrna Vaccines Table 21. Global Pediatric Preventable Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Pediatric Preventable Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Global Pediatric Preventable Vaccine Sales by Type (2027-2032) & (K Units) Table 24. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2026) Table 25. Global Pediatric Preventable Vaccine Sales Market Share by Type (2027-2032) Table 26. Global Pediatric Preventable Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Pediatric Preventable Vaccine Revenue by Type (2021-2026) & (K Units) Table 28. Global Pediatric Preventable Vaccine Revenue by Type (2027-2032) & (K Units) Table 29. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2026) Table 30. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Bacterial Diseases Table 32. Major Manufacturers of Virus Diseases Table 33. Global Pediatric Preventable Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Pediatric Preventable Vaccine Sales by Application (2021-2026) & (K Units) Table 35. Global Pediatric Preventable Vaccine Sales by Application (2027-2032) & (K Units) Table 36. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2026) Table 37. Global Pediatric Preventable Vaccine Sales Market Share by Application (2027-2032) Table 38. Global Pediatric Preventable Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Pediatric Preventable Vaccine Revenue by Application (2021-2026) & (K Units) Table 40. Global Pediatric Preventable Vaccine Revenue by Application (2027-2032) & (K Units) Table 41. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2026) Table 42. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2027-2032) Table 43. Global Pediatric Preventable Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pediatric Preventable Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Pediatric Preventable Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Pediatric Preventable Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Pediatric Preventable Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 50. North America Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Europe Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Europe Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Pediatric Preventable Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pediatric Preventable Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pediatric Preventable Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2021-2026) Table 64. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2027-2032) Table 65. Sanofi Pasteur Company Information Table 66. Sanofi Pasteur Business Overview Table 67. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio Table 69. Sanofi Pasteur Recent Development Table 70. Johnson & Johnson (Janssen) Company Information Table 71. Johnson & Johnson (Janssen) Business Overview Table 72. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio Table 74. Johnson & Johnson (Janssen) Recent Development Table 75. Pfizer Inc. Company Information Table 76. Pfizer Inc. Business Overview Table 77. Pfizer Inc. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio Table 79. Pfizer Inc. Recent Development Table 80. GlaxoSmithKline plc (GSK) Company Information Table 81. GlaxoSmithKline plc (GSK) Business Overview Table 82. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio Table 84. GlaxoSmithKline plc (GSK) Recent Development Table 85. Sinovac Biotech Company Information Table 86. Sinovac Biotech Business Overview Table 87. Sinovac Biotech Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio Table 89. Sinovac Biotech Recent Development Table 90. Sinopharm Group Co., Company Information Table 91. Sinopharm Group Co., Business Overview Table 92. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio Table 94. Sinopharm Group Co., Recent Development Table 95. Serum Institute of India Pvt. Company Information Table 96. Serum Institute of India Pvt. Business Overview Table 97. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio Table 99. Serum Institute of India Pvt. Recent Development Table 100. Novavax, Inc. Company Information Table 101. Novavax, Inc. Business Overview Table 102. Novavax, Inc. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio Table 104. Novavax, Inc. Recent Development Table 105. Moderna, Inc. Company Information Table 106. Moderna, Inc. Business Overview Table 107. Moderna, Inc. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio Table 109. Moderna, Inc. Recent Development Table 110. Merck & Co., Inc. Company Information Table 111. Merck & Co., Inc. Business Overview Table 112. Merck & Co., Inc. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio Table 114. Merck & Co., Inc. Recent Development Table 115. Emergent BioSolutions Inc. Company Information Table 116. Emergent BioSolutions Inc. Business Overview Table 117. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio Table 119. Emergent BioSolutions Inc. Recent Development Table 120. Daiichi Sankyo Company Company Information Table 121. Daiichi Sankyo Company Business Overview Table 122. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio Table 124. Daiichi Sankyo Company Recent Development Table 125. CSL Limited (Seqirus) Company Information Table 126. CSL Limited (Seqirus) Business Overview Table 127. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio Table 129. CSL Limited (Seqirus) Recent Development Table 130. Bharat Biotech International Company Information Table 131. Bharat Biotech International Business Overview Table 132. Bharat Biotech International Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio Table 134. Bharat Biotech International Recent Development Table 135. AstraZeneca plc Company Information Table 136. AstraZeneca plc Business Overview Table 137. AstraZeneca plc Pediatric Preventable Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio Table 139. AstraZeneca plc Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Pediatric Preventable Vaccine Distributors List Table 143. Pediatric Preventable Vaccine Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Pediatric Preventable Vaccine Product Image Figure 2. Global Pediatric Preventable Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Preventable Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Preventable Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Pediatric Preventable Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pediatric Preventable Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Subunit Vaccines Image Figure 9. Inactivated Vaccines Image Figure 10. Live Vaccines Image Figure 11. Viral Vector Vaccines Image Figure 12. Mrna Vaccines Image Figure 13. Global Pediatric Preventable Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pediatric Preventable Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2032) Figure 16. Global Pediatric Preventable Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Pediatric Preventable Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2032) Figure 19. Bacterial Diseases Image Figure 20. Virus Diseases Image Figure 21. Global Pediatric Preventable Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pediatric Preventable Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2032) Figure 24. Global Pediatric Preventable Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Pediatric Preventable Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2032) Figure 27. North America Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 29. U.S. Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 34. Germany Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 41. China Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 49. Brazil Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Pediatric Preventable Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Pediatric Preventable Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pediatric Preventable Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pediatric Preventable Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. North America Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pediatric Preventable Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pediatric Preventable Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pediatric Preventable Vaccine Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pediatric Preventable Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pediatric Preventable Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Vaccines
  • Inactivated Vaccines
  • Live Vaccines
  • Viral Vector Vaccines
  • Mrna Vaccines
Applications
  • Bacterial Diseases
  • Virus Diseases
Companies covered
  • Sanofi Pasteur
  • Johnson & Johnson (Janssen)
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Sinovac Biotech
  • Sinopharm Group Co.,
  • Serum Institute of India Pvt.
  • Novavax, Inc.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • Emergent BioSolutions Inc.
  • Daiichi Sankyo Company
  • CSL Limited (Seqirus)
  • Bharat Biotech International
  • AstraZeneca plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pediatric Preventable Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pediatric Preventable Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pediatric Preventable Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pediatric Preventable Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pediatric Preventable Vaccine Market Dynamics
  1. 2.1 Pediatric Preventable Vaccine Industry Trends
  2. 2.2 Pediatric Preventable Vaccine Industry Drivers
  3. 2.3 Pediatric Preventable Vaccine Industry Opportunities and Challenges
  4. 2.4 Pediatric Preventable Vaccine Industry Restraints
3 Pediatric Preventable Vaccine Market by Manufacturers
  1. 3.1 Global Pediatric Preventable Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pediatric Preventable Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Preventable Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Preventable Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Preventable Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pediatric Preventable Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Pediatric Preventable Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Preventable Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Preventable Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Preventable Vaccine Tier 1, Tier 2, and Tier 3
4 Pediatric Preventable Vaccine Market by Type
  1. 4.1 Pediatric Preventable Vaccine Type Introduction
  2. 4.1.1 Subunit Vaccines
  3. 4.1.2 Inactivated Vaccines
  4. 4.1.3 Live Vaccines
  5. 4.1.4 Viral Vector Vaccines
  6. 4.1.5 Mrna Vaccines
  7. 4.2 Global Pediatric Preventable Vaccine Sales by Type
  8. 4.2.1 Global Pediatric Preventable Vaccine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pediatric Preventable Vaccine Sales by Type (2021-2032)
  10. 4.2.3 Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2032)
  11. 4.3 Global Pediatric Preventable Vaccine Revenue by Type
  12. 4.3.1 Global Pediatric Preventable Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pediatric Preventable Vaccine Revenue by Type (2021-2032)
  14. 4.3.3 Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2032)
5 Pediatric Preventable Vaccine Market by Application
  1. 5.1 Pediatric Preventable Vaccine Application Introduction
  2. 5.1.1 Bacterial Diseases
  3. 5.1.2 Virus Diseases
  4. 5.2 Global Pediatric Preventable Vaccine Sales by Application
  5. 5.2.1 Global Pediatric Preventable Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pediatric Preventable Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pediatric Preventable Vaccine Revenue by Application
  9. 5.3.1 Global Pediatric Preventable Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pediatric Preventable Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pediatric Preventable Vaccine Sales by Region
  1. 6.1 Global Pediatric Preventable Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Preventable Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Preventable Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Pediatric Preventable Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pediatric Preventable Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pediatric Preventable Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pediatric Preventable Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pediatric Preventable Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pediatric Preventable Vaccine Revenue by Region
  1. 7.1 Global Pediatric Preventable Vaccine Revenue by Region
  2. 7.1.1 Global Pediatric Preventable Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pediatric Preventable Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pediatric Preventable Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pediatric Preventable Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pediatric Preventable Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pediatric Preventable Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pediatric Preventable Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pediatric Preventable Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pediatric Preventable Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 Johnson & Johnson (Janssen)
  8. 8.2.1 Johnson & Johnson (Janssen) Company Information
  9. 8.2.2 Johnson & Johnson (Janssen) Business Overview
  10. 8.2.3 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio
  12. 8.2.5 Johnson & Johnson (Janssen) Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 GlaxoSmithKline plc (GSK)
  20. 8.4.1 GlaxoSmithKline plc (GSK) Company Information
  21. 8.4.2 GlaxoSmithKline plc (GSK) Business Overview
  22. 8.4.3 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc (GSK) Recent Developments
  25. 8.5 Sinovac Biotech
  26. 8.5.1 Sinovac Biotech Company Information
  27. 8.5.2 Sinovac Biotech Business Overview
  28. 8.5.3 Sinovac Biotech Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio
  30. 8.5.5 Sinovac Biotech Recent Developments
  31. 8.6 Sinopharm Group Co.,
  32. 8.6.1 Sinopharm Group Co., Company Information
  33. 8.6.2 Sinopharm Group Co., Business Overview
  34. 8.6.3 Sinopharm Group Co., Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio
  36. 8.6.5 Sinopharm Group Co., Recent Developments
  37. 8.7 Serum Institute of India Pvt.
  38. 8.7.1 Serum Institute of India Pvt. Company Information
  39. 8.7.2 Serum Institute of India Pvt. Business Overview
  40. 8.7.3 Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio
  42. 8.7.5 Serum Institute of India Pvt. Recent Developments
  43. 8.8 Novavax, Inc.
  44. 8.8.1 Novavax, Inc. Company Information
  45. 8.8.2 Novavax, Inc. Business Overview
  46. 8.8.3 Novavax, Inc. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio
  48. 8.8.5 Novavax, Inc. Recent Developments
  49. 8.9 Moderna, Inc.
  50. 8.9.1 Moderna, Inc. Company Information
  51. 8.9.2 Moderna, Inc. Business Overview
  52. 8.9.3 Moderna, Inc. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio
  54. 8.9.5 Moderna, Inc. Recent Developments
  55. 8.10 Merck & Co., Inc.
  56. 8.10.1 Merck & Co., Inc. Company Information
  57. 8.10.2 Merck & Co., Inc. Business Overview
  58. 8.10.3 Merck & Co., Inc. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio
  60. 8.10.5 Merck & Co., Inc. Recent Developments
  61. 8.11 Emergent BioSolutions Inc.
  62. 8.11.1 Emergent BioSolutions Inc. Company Information
  63. 8.11.2 Emergent BioSolutions Inc. Business Overview
  64. 8.11.3 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio
  66. 8.11.5 Emergent BioSolutions Inc. Recent Developments
  67. 8.12 Daiichi Sankyo Company
  68. 8.12.1 Daiichi Sankyo Company Company Information
  69. 8.12.2 Daiichi Sankyo Company Business Overview
  70. 8.12.3 Daiichi Sankyo Company Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio
  72. 8.12.5 Daiichi Sankyo Company Recent Developments
  73. 8.13 CSL Limited (Seqirus)
  74. 8.13.1 CSL Limited (Seqirus) Company Information
  75. 8.13.2 CSL Limited (Seqirus) Business Overview
  76. 8.13.3 CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio
  78. 8.13.5 CSL Limited (Seqirus) Recent Developments
  79. 8.14 Bharat Biotech International
  80. 8.14.1 Bharat Biotech International Company Information
  81. 8.14.2 Bharat Biotech International Business Overview
  82. 8.14.3 Bharat Biotech International Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio
  84. 8.14.5 Bharat Biotech International Recent Developments
  85. 8.15 AstraZeneca plc
  86. 8.15.1 AstraZeneca plc Company Information
  87. 8.15.2 AstraZeneca plc Business Overview
  88. 8.15.3 AstraZeneca plc Pediatric Preventable Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio
  90. 8.15.5 AstraZeneca plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Preventable Vaccine Value Chain Analysis
  2. 9.1.1 Pediatric Preventable Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Preventable Vaccine Production Mode & Process
  6. 9.2 Pediatric Preventable Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Preventable Vaccine Distributors
  9. 9.2.3 Pediatric Preventable Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst